Cargando...
Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with cough, sputum production or dyspnoea, and a reduction in lung function, quality of life, and life expectancy. Apart from smoking cessation, no other treatments that slow lung function decline are available. Roflumilast and c...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2020
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7193764/ https://ncbi.nlm.nih.gov/pubmed/32356609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD002309.pub6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|